Table 1 The main laboratory parameters detected in this patient

0–20 IU/ml

<20

0–200 IU/ml

<25

0–10 mg/L

19.5

–

Negative

Autoantibodies

Antinuclear antibody

–

Positive

Antineutrophil cytoplasmic antiboby

–

Positive

Anti jo-1 antibody

–

Negative

Anti-centromere antibody

–

Negative

Anti-double-stranded dna antibody

–

Negative

Anti-histone antibody

–

Negative

Antismith antibody

–

Negative

Anti-rnp antibody

–

Negative

Anti-SS A antibody

–

Negative

Anti-SS B antibody

–

Negative

Anti-ribosomal antibody

–

Negative

Anti-Sc1-70 antibody

Negative

Anti-nucleosome antibody

–

Negative

Lymphocyte subsets

(Flow cytometry)

CD3+ T cell

68 % ± 10.7 %

66.1 %

CD4+ T cell

31.5 % ± 8.8 %

34.2 %

CD8+ T cell

25.7 % ± 6.5 %

19.66 %

CD19 B cell

15.6 % ± 5.8 %

19.1 %

NK cell

5.6 % - 31 %

9 %

CD4+/CD8+

1.5 ± 0.5

1.74

Ig isotypes

IgG

3.22 – 14.0 g/L

6.39

IgM

0.57 – 1.41 g/L

0.82

IgA

0.24 – 1.79 g/L

0.43

Complement C3

0.8 – 1.6 g/L

0.74

Complement C4

0.1 – 0.4 g/L

0.18

0 – 20 KIU/L

104.4

9 – 30 umol/L

19

0.7 – 2.1 mmol/L

1.22

Coagulation test

Activated partial thromboplastin time

26.1 – 40.73 s

29.7^a, over the upper limit of detection^b

Prothrombin time

9.3 –12.9 s

12.8^a, over the upper limit of detection^b

International normalized ratio

0.72 – 1.15

1.09^a, over the upper limit of detection^b

Thrombin time

13.2 – 20.1 s

20^a, over the upper limit of detection^b

Fibrinogen

1.57 – 3.93 g/L

2.43^a, 0.49^b

Blood lipid levels

Total cholesterol

3.1 – 5.8 mmol/L

1.78^a, 3.62^b

Triglyceride

0.23 – 1.7 mmol/L

2.54^a, 4.53^b

High density lipoprotein

0.9 – 1.8 g/L

0.47^a, 1.05^b

Low density lipoprotein

2.07 – 4.1 g/L

1.1^a, 1.8^b

22 – 322 ng/ml

15.4^a, 18699^b

0.02 – 0.5 × 10⁹/L

0.26^a, 4.01^c, 0.01^d